Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 8/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | TYK2 | P29597 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29544780 | 0.92 | EGFR (0.36) | EGFRABCG2TYK2ATMCCNT1 | |
| SCHEMBL29544700 | 0.89 | EGFR (0.40) | EGFRTYK2CCNT1CDK9CSF1R | |
| SCHEMBL29544572 | 0.88 | EGFR (0.40) | EGFRTYK2CCNT1CDK9CSF1R | |
| SCHEMBL29544468 | 0.85 | EGFR (0.41) | EGFRTYK2CCNT1CDK9 | |
| SCHEMBL29544647 | 0.84 | EGFR (0.40) | EGFRKDR | |
| SCHEMBL29545142 | 0.82 | CSF1R (0.39) | EGFRTYK2CCNT1CDK9PDGFRA | |
| SCHEMBL29545092 | 0.80 | EGFR (0.39) | EGFRTYK2CCNT1CDK9PDGFRA | |
| SCHEMBL29544881 | 0.80 | ATM (0.38) | EGFRABCG2ATMCCNT1CDK9 | |
| SCHEMBL29544736 | 0.80 | EGFR (0.40) | EGFRTYK2CCNT1CDK9 | |
| SCHEMBL29545140 | 0.79 | EGFR (0.42) | EGFRTYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022072634-A1 | BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER | SCORPION THERAPEUTICS, INC. (US) | 2022-04-07 | — | — | WO | disclosed |